Card image cap

Al Franken's Public Statements on Issue: Drugs

Current Issue:

Drugs

Current Speech Type:

Letter

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Page 1 of 2
Date Title
11/08/2017 Letter to Jeff Sessions, Attorney General - Provide Guidance on Boosting Support for Forensic Labs In Efforts to Combat Opioid Epidemic
11/07/2017 Letter to Mr. Brenton L. Saunders, CEO, Allergan plc - Monopoly Keeps Price of Drug High, Limits Competition
11/03/2017 Letter to the Hon. Donald J. Trump, President - Support Funding to Stem Opioid Epidemic
10/25/2017 Letter to President Donald J. Trump - Allow Government to Negotiate Lower Prices for Naloxone
10/25/2017 Letter to President Donald Trump - Senators Call on President to Allow Government to Negotiate Lower Prices for Naloxone, a Life-Saving Opioid Overdose Reversal Drug
10/20/2017 Letter to Eric Hargan, Acting Secretary of Health and Human Services, Robert Patterson, Acting Administrator of Drug Enforcement Administration - Ensuring Patient Access and Effective Drug Enforcement Act
08/04/2017 Letter to the Honorable Scott Gottlieb, Commissioner of Food and Drug Administration - FDA Tobacco Regulations
07/11/2017 Letter to the Hon. Chuck Rosenberg, Acting Administrator of the United States Drug Enforcement Administration - Senators Urge DEA to Lower Opioid Quotas to Combat Prescription Drug Abuse
05/24/2017 Letter to the Hon. Donald J. Trump, President - Delay Visit of Filipino Leader, Denounce Human Rights Abuses
05/17/2017 Letter to the Honorable Roy Blunt and Patty Murray, Chairman and Ranking Member of Senate Appropriations Subcommittee on Labor, HHS, and Education, and the Honorable Thad Cochran and Patrick Leahy, Chairman and Vice-Chairman of Senate Appropriations Committee - Increase Funding to Combat Opioid Epidemic
05/09/2017 Letter to the Hon. Mick Mulvaney, Director of the Office of Management and Budget - Fully Fund Office of National Drug Control Policy
05/03/2017 Letter to President Donald Trump - Dismissal of U.S. Surgeon General Vivek Murthy
04/26/2017 Letter to the Hon. Mitch McConnell, Senate Majority Leader, and the Hon. Paul Ryan, Speaker of the House - Funding for Opioid Crisis and Medical Research
03/21/2017 Letter to the Hon. Mitch McConnell - Regarding Opioid Crisis
02/03/2017 Letter to the Hon. Donald Trump - Regarding Opioid Crisis
02/03/2017 Letter to the Hon. Donald J. Trump - Healthcare Repeal and the Opioid Crisis
02/03/2017 Letter to the Hon. Donald Trump - Regarding Fighting the Opioid Crisis
12/14/2016 Letter to the Hon. Jamal El-Hindi, Acting Director of Financial Enforcement Network - Regarding Guidance on Banking Services
12/13/2016 Letter to Jamal El-Hindi, Acting Director of Financial Crimes Enforcement Network - Guidance on Banking Service for Vendors Working with Legal Marijuana Businesses
08/30/2016 Letter to Ms. Heather Bresch, Chief Executive Officer of Mylan - Concerns About Mylan's EpiPen Price HIke
08/02/2016 Letter to The Honorable Andy Slavitt, Acting Administrator, Centers for Medicare & Medicaid Services - Urging CMS to Expand Substance Abuse Treatment Coverage
07/14/2016 Letter to Mitch McConnell, Majority Leader of the United States Senate - As Congress Clears Comprehensive Addiction and Recovery Bill, Reed Calls for Emergency Funding for Opioid Epidemic
07/13/2016 Letter to The Honorable Mitch McConnell. Majority Leader, United States Senate - Commit to Passing Real, Immediate Funding to Fight Opioid and Heroin Epidemic and Actually Carry Out Programs Authorized in CARA Bill
06/01/2016 Letter to The Honorable Sylvia M. Burwell, Secretary of Health and Human Services - Urging DHHS to Increase Access to Opioid Addiction Treatment
03/28/2016 Letter to the Honorable Sylvia M. Burwell, Secretary of Health and Human Services and Francis Collins, Director of National Institutes of Health - Act Now on Drug Affordability
Page 1 of 2
arrow_upward